The Cooper Companies, Inc. (COO)
USD 71.5
(-2.47%)
USD 71.5
(-2.47%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 294.2 Million USD | -23.74% |
| 2022 | 385.8 Million USD | -86.9% |
| 2021 | 2.94 Billion USD | 1135.19% |
| 2020 | 238.4 Million USD | -48.92% |
| 2019 | 466.7 Million USD | 233.6% |
| 2018 | 139.9 Million USD | -62.48% |
| 2017 | 372.9 Million USD | 36.14% |
| 2016 | 273.91 Million USD | 34.59% |
| 2015 | 203.52 Million USD | -24.58% |
| 2014 | 269.85 Million USD | -8.88% |
| 2013 | 296.15 Million USD | 19.25% |
| 2012 | 248.33 Million USD | 41.56% |
| 2011 | 175.43 Million USD | 55.52% |
| 2010 | 112.8 Million USD | 12.19% |
| 2009 | 100.54 Million USD | 53.56% |
| 2008 | 65.47 Million USD | 685.03% |
| 2007 | -11.19 Million USD | -116.9% |
| 2006 | 66.23 Million USD | -27.79% |
| 2005 | 91.72 Million USD | -1.19% |
| 2004 | 92.82 Million USD | 34.98% |
| 2003 | 68.77 Million USD | 40.71% |
| 2002 | 48.87 Million USD | 31.61% |
| 2001 | 37.13 Million USD | 28.2% |
| 2000 | 28.96 Million USD | 15.41% |
| 1999 | 25.1 Million USD | -36.93% |
| 1998 | 39.8 Million USD | 26.75% |
| 1997 | 31.4 Million USD | 89.16% |
| 1996 | 16.6 Million USD | 16500.0% |
| 1995 | 100 Thousand USD | 102.13% |
| 1994 | -4.7 Million USD | 89.98% |
| 1993 | -46.9 Million USD | -88.35% |
| 1992 | -24.9 Million USD | -0.4% |
| 1991 | -24.8 Million USD | -1358.82% |
| 1990 | -1.7 Million USD | 89.57% |
| 1989 | -16.3 Million USD | 89.26% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 104.7 Million USD | 17.77% |
| 2024 Q2 | 88.9 Million USD | 9.48% |
| 2024 Q1 | 81.2 Million USD | -3.91% |
| 2023 Q4 | 84.5 Million USD | -0.94% |
| 2023 Q2 | 39.8 Million USD | -52.96% |
| 2023 Q3 | 85.3 Million USD | 114.32% |
| 2023 Q1 | 84.6 Million USD | 28.96% |
| 2023 FY | 294.2 Million USD | -23.74% |
| 2022 Q3 | 98.4 Million USD | -22.27% |
| 2022 Q2 | 126.6 Million USD | 32.84% |
| 2022 Q4 | 65.6 Million USD | -33.33% |
| 2022 FY | 385.8 Million USD | -86.9% |
| 2022 Q1 | 95.3 Million USD | -13.6% |
| 2021 Q1 | 2.1 Billion USD | 2487.56% |
| 2021 Q3 | 615.8 Million USD | 424.09% |
| 2021 Q4 | 110.3 Million USD | -82.09% |
| 2021 Q2 | 117.5 Million USD | -94.41% |
| 2021 FY | 2.94 Billion USD | 1135.19% |
| 2020 FY | 238.4 Million USD | -48.92% |
| 2020 Q1 | 90.5 Million USD | -25.21% |
| 2020 Q3 | 55.2 Million USD | 380.0% |
| 2020 Q4 | 81.2 Million USD | 47.1% |
| 2020 Q2 | 11.5 Million USD | -87.29% |
| 2019 Q4 | 121 Million USD | 0.75% |
| 2019 FY | 466.7 Million USD | 233.6% |
| 2019 Q1 | 103.2 Million USD | 2.58% |
| 2019 Q2 | 122.4 Million USD | 18.6% |
| 2019 Q3 | 120.1 Million USD | -1.88% |
| 2018 Q3 | 100.8 Million USD | 65.52% |
| 2018 Q2 | 60.9 Million USD | 149.71% |
| 2018 Q1 | -122.5 Million USD | -238.26% |
| 2018 FY | 139.9 Million USD | -62.48% |
| 2018 Q4 | 100.6 Million USD | -0.2% |
| 2017 Q3 | 103.6 Million USD | -1.24% |
| 2017 FY | 372.9 Million USD | 36.14% |
| 2017 Q4 | 88.6 Million USD | -14.48% |
| 2017 Q1 | 75.8 Million USD | 25.27% |
| 2017 Q2 | 104.9 Million USD | 38.39% |
| 2016 Q3 | 87.92 Million USD | 18.62% |
| 2016 FY | 273.91 Million USD | 34.59% |
| 2016 Q4 | 60.5 Million USD | -31.18% |
| 2016 Q1 | 51.35 Million USD | 40.01% |
| 2016 Q2 | 74.12 Million USD | 44.34% |
| 2015 Q3 | 44.95 Million USD | -25.96% |
| 2015 FY | 203.52 Million USD | -24.58% |
| 2015 Q4 | 36.67 Million USD | -18.4% |
| 2015 Q2 | 60.71 Million USD | -0.76% |
| 2015 Q1 | 61.17 Million USD | 98.72% |
| 2014 Q2 | 79.16 Million USD | 10.18% |
| 2014 Q4 | 30.78 Million USD | -65.04% |
| 2014 Q1 | 71.84 Million USD | 25.17% |
| 2014 FY | 269.85 Million USD | -8.88% |
| 2014 Q3 | 88.06 Million USD | 11.25% |
| 2013 Q3 | 88.95 Million USD | 18.39% |
| 2013 Q4 | 57.39 Million USD | -35.47% |
| 2013 Q1 | 74.66 Million USD | 3.82% |
| 2013 Q2 | 75.13 Million USD | 0.63% |
| 2013 FY | 296.15 Million USD | 19.25% |
| 2012 Q1 | 54.62 Million USD | -3.56% |
| 2012 FY | 248.33 Million USD | 41.56% |
| 2012 Q4 | 71.92 Million USD | 7.54% |
| 2012 Q3 | 66.87 Million USD | 21.77% |
| 2012 Q2 | 54.92 Million USD | 0.55% |
| 2011 Q3 | 38.13 Million USD | 7.85% |
| 2011 FY | 175.43 Million USD | 55.52% |
| 2011 Q4 | 56.63 Million USD | 48.51% |
| 2011 Q2 | 35.36 Million USD | -21.93% |
| 2011 Q1 | 45.29 Million USD | -6.02% |
| 2010 FY | 112.8 Million USD | 12.19% |
| 2010 Q4 | 48.19 Million USD | 21.32% |
| 2010 Q3 | 39.72 Million USD | 791.54% |
| 2010 Q2 | 4.45 Million USD | -78.18% |
| 2010 Q1 | 20.42 Million USD | -32.19% |
| 2009 Q4 | 30.11 Million USD | 37.47% |
| 2009 Q1 | 23.87 Million USD | -19.02% |
| 2009 Q3 | 21.9 Million USD | -11.12% |
| 2009 FY | 100.54 Million USD | 53.56% |
| 2009 Q2 | 24.64 Million USD | 3.25% |
| 2008 Q3 | 17.87 Million USD | 59.05% |
| 2008 Q4 | 29.47 Million USD | 64.88% |
| 2008 Q1 | 6.87 Million USD | 128.43% |
| 2008 Q2 | 11.24 Million USD | 63.46% |
| 2008 FY | 65.47 Million USD | 685.03% |
| 2007 Q2 | -527 Thousand USD | -109.85% |
| 2007 FY | -11.19 Million USD | -116.9% |
| 2007 Q4 | -24.19 Million USD | -395.76% |
| 2007 Q3 | 8.18 Million USD | 1652.18% |
| 2007 Q1 | 5.34 Million USD | -60.68% |
| 2006 Q3 | 20.97 Million USD | 53.11% |
| 2006 Q1 | 17.95 Million USD | 181.85% |
| 2006 FY | 66.23 Million USD | -27.79% |
| 2006 Q4 | 13.6 Million USD | -35.16% |
| 2006 Q2 | 13.7 Million USD | -23.69% |
| 2005 Q1 | 18.48 Million USD | -35.64% |
| 2005 Q3 | 37.35 Million USD | 26.59% |
| 2005 FY | 91.72 Million USD | -1.19% |
| 2005 Q2 | 29.51 Million USD | 59.63% |
| 2005 Q4 | 6.37 Million USD | -82.95% |
| 2004 Q4 | 28.72 Million USD | 19.44% |
| 2004 Q2 | 21.69 Million USD | 18.22% |
| 2004 Q1 | 18.35 Million USD | -12.77% |
| 2004 FY | 92.82 Million USD | 34.98% |
| 2004 Q3 | 24.04 Million USD | 10.83% |
| 2003 Q1 | 13.85 Million USD | -14.43% |
| 2003 FY | 68.77 Million USD | 40.71% |
| 2003 Q3 | 18.66 Million USD | 22.69% |
| 2003 Q2 | 15.21 Million USD | 9.79% |
| 2003 Q4 | 21.04 Million USD | 12.74% |
| 2002 Q1 | 9.4 Million USD | -20.0% |
| 2002 Q2 | 9.91 Million USD | 5.45% |
| 2002 Q4 | 16.19 Million USD | 21.18% |
| 2002 FY | 48.87 Million USD | 31.61% |
| 2002 Q3 | 13.36 Million USD | 34.71% |
| 2001 Q2 | 8.71 Million USD | 38.06% |
| 2001 Q3 | 10.36 Million USD | 18.96% |
| 2001 Q4 | 11.75 Million USD | 13.46% |
| 2001 FY | 37.13 Million USD | 28.2% |
| 2001 Q1 | 6.3 Million USD | -31.04% |
| 2000 Q3 | 8.66 Million USD | 28.06% |
| 2000 Q4 | 9.14 Million USD | 5.63% |
| 2000 Q1 | 4.4 Million USD | -41.33% |
| 2000 FY | 28.96 Million USD | 15.41% |
| 2000 Q2 | 6.76 Million USD | 53.7% |
| 1999 Q3 | 6.5 Million USD | -8.45% |
| 1999 FY | 25.1 Million USD | -36.93% |
| 1999 Q2 | 7.1 Million USD | 82.05% |
| 1999 Q1 | 3.9 Million USD | -74.17% |
| 1999 Q4 | 7.5 Million USD | 15.38% |
| 1998 Q1 | 6 Million USD | -61.29% |
| 1998 Q3 | 10.2 Million USD | 20.0% |
| 1998 Q4 | 15.1 Million USD | 48.04% |
| 1998 FY | 39.8 Million USD | 26.75% |
| 1998 Q2 | 8.5 Million USD | 41.67% |
| 1997 Q2 | 5.4 Million USD | 63.64% |
| 1997 Q1 | 3.3 Million USD | -61.18% |
| 1997 Q4 | 15.5 Million USD | 115.28% |
| 1997 FY | 31.4 Million USD | 89.16% |
| 1997 Q3 | 7.2 Million USD | 33.33% |
| 1996 Q4 | 8.5 Million USD | 80.85% |
| 1996 Q2 | 2.8 Million USD | 300.0% |
| 1996 Q1 | 700 Thousand USD | 119.44% |
| 1996 FY | 16.6 Million USD | 16500.0% |
| 1996 Q3 | 4.7 Million USD | 67.86% |
| 1995 FY | 100 Thousand USD | 102.13% |
| 1995 Q4 | -3.6 Million USD | -228.57% |
| 1995 Q3 | 2.8 Million USD | 366.67% |
| 1995 Q1 | 300 Thousand USD | -75.0% |
| 1995 Q2 | 600 Thousand USD | 100.0% |
| 1994 Q2 | -3.9 Million USD | 25.0% |
| 1994 Q4 | 1.2 Million USD | -60.0% |
| 1994 Q3 | 3 Million USD | 176.92% |
| 1994 Q1 | -5.2 Million USD | 54.78% |
| 1994 FY | -4.7 Million USD | 89.98% |
| 1993 FY | -46.9 Million USD | -88.35% |
| 1993 Q1 | -1.8 Million USD | 89.47% |
| 1993 Q2 | -19.9 Million USD | -1005.56% |
| 1993 Q3 | -13.7 Million USD | 31.16% |
| 1993 Q4 | -11.5 Million USD | 16.06% |
| 1992 Q4 | -17.1 Million USD | -83.87% |
| 1992 Q1 | 400 Thousand USD | 106.45% |
| 1992 FY | -24.9 Million USD | -0.4% |
| 1992 Q2 | 700 Thousand USD | 75.0% |
| 1992 Q3 | -9.3 Million USD | -1428.57% |
| 1991 Q3 | -5.1 Million USD | 37.8% |
| 1991 Q1 | -5.3 Million USD | 0.0% |
| 1991 Q2 | -8.2 Million USD | -54.72% |
| 1991 Q4 | -6.2 Million USD | -21.57% |
| 1991 FY | -24.8 Million USD | -1358.82% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 FY | -1.7 Million USD | 89.57% |
| 1990 Q3 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 FY | -16.3 Million USD | 89.26% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 564.602% |
| AngioDynamics, Inc. | -184.34 Million USD | 259.589% |
| AtriCure, Inc. | -30.43 Million USD | 1066.555% |
| Avinger, Inc. | -18.32 Million USD | 1705.895% |
| Azenta, Inc. | -14.25 Million USD | 2163.548% |
| BioLife Solutions, Inc. | -66.42 Million USD | 542.892% |
| Daxor Corporation | 280.64 Thousand USD | -104731.813% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 2035.781% |
| Femasys Inc. | -14.24 Million USD | 2164.978% |
| GlucoTrack, Inc. | -7.09 Million USD | 4245.414% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 8714.934% |
| Hologic, Inc. | 789.5 Million USD | 62.736% |
| ICU Medical, Inc. | -29.65 Million USD | 1092.076% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 83.637% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 2241.028% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | -877.246% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 4515.145% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 4515.145% |
| Masimo Corporation | 81.5 Million USD | -260.982% |
| Microbot Medical Inc. | -10.74 Million USD | 2839.292% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | -2430.662% |
| Merit Medical Systems, Inc. | 94.41 Million USD | -211.616% |
| Nephros, Inc. | -1.57 Million USD | 18779.365% |
| NovoCure Limited | -207.04 Million USD | 242.096% |
| NEXGEL, Inc. | -3.15 Million USD | 9418.974% |
| NEXGEL, Inc. | -3.15 Million USD | 9418.974% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 410.272% |
| OraSure Technologies, Inc. | 53.65 Million USD | -448.318% |
| Pro-Dex, Inc. | 2.12 Million USD | -13731.688% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 796.991% |
| Predictive Oncology Inc. | -13.98 Million USD | 2203.838% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 10068.228% |
| QuidelOrtho Corporation | -10.1 Million USD | 3012.871% |
| Repligen Corporation | 41.57 Million USD | -607.603% |
| Sanara MedTech Inc. | -4.3 Million USD | 6936.777% |
| STAAR Surgical Company | 21.34 Million USD | -1278.18% |
| Sharps Technology, Inc. | -9.84 Million USD | 3089.34% |
| Utah Medical Products, Inc. | 16.63 Million USD | -1668.56% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 322.879% |
| Jin Medical International Ltd. | 2.87 Million USD | -10121.56% |